413 related articles for article (PubMed ID: 35372329)
21. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons.
Gopal PP; Nirschl JJ; Klinman E; Holzbaur EL
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2466-E2475. PubMed ID: 28265061
[TBL] [Abstract][Full Text] [Related]
22. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
[TBL] [Abstract][Full Text] [Related]
23. The key role of solvent in condensation: Mapping water in liquid-liquid phase-separated FUS.
Ahlers J; Adams EM; Bader V; Pezzotti S; Winklhofer KF; Tatzelt J; Havenith M
Biophys J; 2021 Apr; 120(7):1266-1275. PubMed ID: 33515602
[TBL] [Abstract][Full Text] [Related]
24. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain.
Babinchak WM; Haider R; Dumm BK; Sarkar P; Surewicz K; Choi JK; Surewicz WK
J Biol Chem; 2019 Apr; 294(16):6306-6317. PubMed ID: 30814253
[TBL] [Abstract][Full Text] [Related]
25. Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.
Bhopatkar AA; Uversky VN; Rangachari V
J Biol Chem; 2020 Feb; 295(8):2506-2519. PubMed ID: 31911437
[TBL] [Abstract][Full Text] [Related]
26. Biomolecular condensates in cell biology and virology: Phase-separated membraneless organelles (MLOs).
Sehgal PB; Westley J; Lerea KM; DiSenso-Browne S; Etlinger JD
Anal Biochem; 2020 May; 597():113691. PubMed ID: 32194074
[TBL] [Abstract][Full Text] [Related]
27. The pathophysiology of neurodegenerative disease: Disturbing the balance between phase separation and irreversible aggregation.
Webber CJ; Lei SE; Wolozin B
Prog Mol Biol Transl Sci; 2020; 174():187-223. PubMed ID: 32828466
[TBL] [Abstract][Full Text] [Related]
28. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
29. Electrostatic modulation of hnRNPA1 low-complexity domain liquid-liquid phase separation and aggregation.
Tsoi PS; Quan MD; Choi KJ; Dao KM; Ferreon JC; Ferreon ACM
Protein Sci; 2021 Jul; 30(7):1408-1417. PubMed ID: 33982369
[TBL] [Abstract][Full Text] [Related]
30. Emerging Roles of Liquid-Liquid Phase Separation in Cancer: From Protein Aggregation to Immune-Associated Signaling.
Lu J; Qian J; Xu Z; Yin S; Zhou L; Zheng S; Zhang W
Front Cell Dev Biol; 2021; 9():631486. PubMed ID: 34235141
[TBL] [Abstract][Full Text] [Related]
31. Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites.
Yoshizawa T; Ali R; Jiou J; Fung HYJ; Burke KA; Kim SJ; Lin Y; Peeples WB; Saltzberg D; Soniat M; Baumhardt JM; Oldenbourg R; Sali A; Fawzi NL; Rosen MK; Chook YM
Cell; 2018 Apr; 173(3):693-705.e22. PubMed ID: 29677513
[TBL] [Abstract][Full Text] [Related]
32. ATP enhances at low concentrations but dissolves at high concentrations liquid-liquid phase separation (LLPS) of ALS/FTD-causing FUS.
Kang J; Lim L; Song J
Biochem Biophys Res Commun; 2018 Oct; 504(2):545-551. PubMed ID: 30205960
[TBL] [Abstract][Full Text] [Related]
33. Friend or foe-Post-translational modifications as regulators of phase separation and RNP granule dynamics.
Hofweber M; Dormann D
J Biol Chem; 2019 May; 294(18):7137-7150. PubMed ID: 30587571
[TBL] [Abstract][Full Text] [Related]
34. Altered Phase Separation and Cellular Impact in
Solomon DA; Smikle R; Reid MJ; Mizielinska S
Front Cell Neurosci; 2021; 15():664151. PubMed ID: 33967699
[TBL] [Abstract][Full Text] [Related]
35. More than a bystander: RNAs specify multifaceted behaviors of liquid-liquid phase-separated biomolecular condensates.
Zheng H; Zhang H
Bioessays; 2024 Mar; 46(3):e2300203. PubMed ID: 38175843
[TBL] [Abstract][Full Text] [Related]
36. Protein aggregation in amyotrophic lateral sclerosis.
Blokhuis AM; Groen EJ; Koppers M; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2013 Jun; 125(6):777-94. PubMed ID: 23673820
[TBL] [Abstract][Full Text] [Related]
37. [Molecular mechanism of amyotrophic lateral sclerosis (ALS) from the viewpoint of the formation and degeneration of transactive response DNA-binding protein 43 kDa (TDP-43) inclusions].
Kasahara S; Ishihara T; Koike Y; Sugai A; Onodera O
Rinsho Shinkeigaku; 2020 Feb; 60(2):109-116. PubMed ID: 31956195
[TBL] [Abstract][Full Text] [Related]
38. [Molecular Pathogenesis of Amyotrophic Lateral Sclerosis].
Tsuboguchi S; Ishihara T; Sugai A; Yokoseki A; Onodera O
Brain Nerve; 2019 Nov; 71(11):1183-1189. PubMed ID: 31722304
[TBL] [Abstract][Full Text] [Related]
39. A Spectrophotometric Turbidity Assay to Study Liquid-Liquid Phase Separation of UBQLN2 In Vitro.
Raymond-Smiedy P; Bucknor B; Yang Y; Zheng T; Castañeda CA
Methods Mol Biol; 2023; 2551():515-541. PubMed ID: 36310223
[TBL] [Abstract][Full Text] [Related]
40. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
